Immix Biopharma (IMMX) Other Non-Current Assets (2022 - 2026)
Immix Biopharma (IMMX) reported Other Non-Current Assets of $20418.0 for Q1 2026, little changed on a YoY basis from $20418.0 in Q1 2025, and little changed sequentially from $20418.0 in Q4 2025.
Immix Biopharma (IMMX) Other Non-Current Assets (2022 - 2026) Analysis & Trends
Immix Biopharma (IMMX) has 5 years of Other Non-Current Assets data on file, last reported at $20418.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets changed 0.0% year-over-year to $20418.0; the trailing twelve-month figure through Mar 2026 stood at $20418.0 (changed 0.0% YoY), and the FY2025 full-year result was $20418.0, changed 0.0% from the prior year.
- Other Non-Current Assets steadied at $20418.0 in Q1 2026, from $20418.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $175131.0 in Q1 2023 to a low of $6724.0 in Q4 2022.
- A 5-year average of $40425.5 and a median of $20418.0 in 2024 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets plunged 88.34% in 2024 and changed 0.0% in 2025, its largest moves.
- Tracing IMMX's Other Non-Current Assets over 5 years: stood at $6724.0 in 2022, then jumped by 1434.67% to $103191.0 in 2023, then plunged by 80.21% to $20418.0 in 2024, then changed by 0.0% to $20418.0 in 2025, then changed by 0.0% to $20418.0 in 2026.
- Business Quant data shows IMMX's Other Non-Current Assets at $20418.0 in Q1 2026, $20418.0 in Q4 2025, and $20418.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Immix Biopharma | 487.25 Mn | 487.25 Mn | - | 20,418.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,418.00 |
| Dec 31, 2025 | 20,418.00 |
| Sep 30, 2025 | 20,418.00 |
| Jun 30, 2025 | 20,418.00 |
| Mar 31, 2025 | 20,418.00 |
| Dec 31, 2024 | 20,418.00 |
| Sep 30, 2024 | 20,418.00 |
| Jun 30, 2024 | 20,418.00 |
| Mar 31, 2024 | 20,418.00 |
| Sep 30, 2023 | 103,191.00 |
| Jun 30, 2023 | 56,724.00 |
| Mar 31, 2023 | 175,131.00 |
| Dec 31, 2022 | 6,724.00 |